PL2057467T3 - Sposób diagnozowania choroby z udziałem przeciwciała przeciwko receptorowi AT1 - Google Patents

Sposób diagnozowania choroby z udziałem przeciwciała przeciwko receptorowi AT1

Info

Publication number
PL2057467T3
PL2057467T3 PL07802440T PL07802440T PL2057467T3 PL 2057467 T3 PL2057467 T3 PL 2057467T3 PL 07802440 T PL07802440 T PL 07802440T PL 07802440 T PL07802440 T PL 07802440T PL 2057467 T3 PL2057467 T3 PL 2057467T3
Authority
PL
Poland
Prior art keywords
receptor antibody
diagnosis
receptor
disease involving
disease
Prior art date
Application number
PL07802440T
Other languages
English (en)
Inventor
Kai Schulze-Forster
Harald Heidecke
Original Assignee
Celltrend Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltrend Gmbh filed Critical Celltrend Gmbh
Publication of PL2057467T3 publication Critical patent/PL2057467T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
PL07802440T 2006-08-04 2007-07-31 Sposób diagnozowania choroby z udziałem przeciwciała przeciwko receptorowi AT1 PL2057467T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06016296A EP1884775B1 (en) 2006-08-04 2006-08-04 Method for diagnosis of a disease involving an anti-AT1-receptor antibody
PCT/EP2007/057910 WO2008015218A2 (en) 2006-08-04 2007-07-31 Method for diagnosis of a disease involving an anti-at1-receptor antibody
EP07802440A EP2057467B1 (en) 2006-08-04 2007-07-31 Method for diagnosis of a disease involving an anti-at1-receptor antibody

Publications (1)

Publication Number Publication Date
PL2057467T3 true PL2057467T3 (pl) 2011-12-30

Family

ID=37401029

Family Applications (2)

Application Number Title Priority Date Filing Date
PL06016296T PL1884775T3 (pl) 2006-08-04 2006-08-04 Sposób rozpoznawania chorób związanych z przeciwciałem przeciwko receptorowi AT 1
PL07802440T PL2057467T3 (pl) 2006-08-04 2007-07-31 Sposób diagnozowania choroby z udziałem przeciwciała przeciwko receptorowi AT1

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL06016296T PL1884775T3 (pl) 2006-08-04 2006-08-04 Sposób rozpoznawania chorób związanych z przeciwciałem przeciwko receptorowi AT 1

Country Status (7)

Country Link
US (1) US8425877B2 (pl)
EP (2) EP1884775B1 (pl)
AT (2) ATE454630T1 (pl)
DE (1) DE602006011602D1 (pl)
ES (2) ES2336350T3 (pl)
PL (2) PL1884775T3 (pl)
WO (1) WO2008015218A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10123929A1 (de) 2001-05-11 2002-11-21 Celltrend Gmbh Verfahren zur Vorhersage eines Transplantatabstoßungsrisikos und immunologischer Testkit
PL1884775T3 (pl) 2006-08-04 2010-06-30 Celltrend Gmbh Sposób rozpoznawania chorób związanych z przeciwciałem przeciwko receptorowi AT 1
EP1884776A1 (en) 2006-08-04 2008-02-06 Celltrend GmbH Method for diagnosis of a disease involving an anti-endothelin-receptor antibody
BR112012026006A2 (pt) * 2010-04-12 2019-09-24 Cell Trend GmbH método para diagnose de esclerose múltipla envolvendo anticorpo antirreceptor at1
US8483415B2 (en) 2010-06-18 2013-07-09 Motorola Mobility Llc Antenna system with parasitic element for hearing aid compliant electromagnetic emission
WO2017075380A1 (en) * 2015-10-30 2017-05-04 The Johns Hopkins University Angiotensin receptor autoantibodies as biomarker for effective usage of angiotensin receptor blockers
US9989543B2 (en) 2016-01-11 2018-06-05 Autotelic, Llc Composition, device, and method for detecting olmesartan and improving compliance in treating hypertension
CN108948183B (zh) * 2018-06-05 2022-01-28 武汉华纪元生物技术开发有限公司 α1受体和AT1受体抗原类似物多肽及其抗体检测试剂盒和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2866182B2 (ja) 1990-10-08 1999-03-08 日本ケミファ株式会社 エンドセリン受容体
FR2787330A1 (fr) 1998-12-18 2000-06-23 Sanofi Sa Composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et un immunosuppresseur pour la prevention ou le traitement des complications vasculaires du rejet de greffe
AU2429100A (en) 1998-12-24 2000-07-31 Max-Delbruck-Centrum Fur Molekulare Medizin Peptides of the at1 receptor and their use for preeclampsia and malign hypertension
DE19954305A1 (de) * 1998-12-24 2000-06-29 Max Delbrueck Centrum Peptide des AT¶1¶-Rezeptors und ihre Verwendung, insbesondere für die Diagnostider Präeklampsie
CA2314811A1 (en) * 2000-08-02 2002-02-02 Brian Archibald Macvicar Autoimmunity to angiotensin at1 receptors in schizophrenia
DE10123929A1 (de) * 2001-05-11 2002-11-21 Celltrend Gmbh Verfahren zur Vorhersage eines Transplantatabstoßungsrisikos und immunologischer Testkit
US20030078190A1 (en) * 2001-05-25 2003-04-24 Weinberg Marc S. Methods for tissue protection using highly effective inhibition of the renin-angiotensin system
WO2004051280A2 (de) 2002-11-29 2004-06-17 Max-Delbrück-Centrum für Molekulare Medizin Bestimmung agonistischer autoantikörper
US20060135422A1 (en) * 2003-04-17 2006-06-22 Moskowitz David W Use of angiotensin receptor blockers (ARBs) to treat diseases associated with excess ACE
WO2006060336A2 (en) 2004-11-30 2006-06-08 The Johns Hopkins University Endothelin-2 and retinal damage
PL1884775T3 (pl) 2006-08-04 2010-06-30 Celltrend Gmbh Sposób rozpoznawania chorób związanych z przeciwciałem przeciwko receptorowi AT 1
EP1884776A1 (en) * 2006-08-04 2008-02-06 Celltrend GmbH Method for diagnosis of a disease involving an anti-endothelin-receptor antibody

Also Published As

Publication number Publication date
ATE454630T1 (de) 2010-01-15
EP1884775A1 (en) 2008-02-06
WO2008015218A2 (en) 2008-02-07
EP1884775B1 (en) 2010-01-06
ATE518139T1 (de) 2011-08-15
WO2008015218A3 (en) 2008-07-03
ES2336350T3 (es) 2010-04-12
US8425877B2 (en) 2013-04-23
DE602006011602D1 (de) 2010-02-25
PL1884775T3 (pl) 2010-06-30
EP2057467B1 (en) 2011-07-27
US20100098688A1 (en) 2010-04-22
ES2369798T3 (es) 2011-12-07
EP2057467A2 (en) 2009-05-13

Similar Documents

Publication Publication Date Title
PL2057467T3 (pl) Sposób diagnozowania choroby z udziałem przeciwciała przeciwko receptorowi AT1
EP3761034A3 (en) Urine biomarkers for prediction of recovery after acute kidney injury: proteomics
MX361944B (es) Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales.
WO2010091049A3 (en) Diagnosis and treatment of cancer
MX365029B (es) Biomarcadores de lesion renal.
WO2007137285A3 (en) Fluid access interface
WO2008122670A3 (en) Human diabetes susceptibility tnfrsf10b gene
UA101167C2 (ru) Фармацевтическая композиция, предназначенная для лечения глазной болезни
AR086734A1 (es) Metodos de diagnostico de la enfermedad tromboembolica
DK1915620T3 (da) Diagnose, behandling og prævention af vaskulære sygdomme ved hjælp af IL-1alpha-autoantistoffer
DE602007007775D1 (de) Reagenz für hämoglobinabbau
WO2009001545A1 (ja) 移植片対宿主疾患の検査および治療方法
EA201490883A1 (ru) ПРИМЕНЕНИЕ АНТИТЕЛА К α-СИНУКЛЕИНУ ДЛЯ ДИАГНОСТИКИ ПОВЫШЕННОГО УРОВНЯ α-СИНУКЛЕИНА В МОЗГЕ
DE502006008028D1 (de) Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen
CY1122202T1 (el) Προσδιορισμος κινδυνου για θεραπεια αντιβιοτικων σε ασθενεις οι οποιοι υποφερουν απο πρωτοπαθη μη μολυσματικη νοσο δια καθορισμου του επιπεδου προκαλσιτονινης
TW200740441A (en) Methods and reagents for the treatment of inflammatory disorders
FR2881437B1 (fr) Procede pour le diagnostic/pronostic d'un syndrome septique
WO2009027703A3 (en) Identifying organ damage
BR112013031431A2 (pt) método para o diagnóstico da doença de gaucher
WO2010047938A3 (en) Mmp activation peptide detection in biological samples
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins
FR2930036B1 (fr) Procede de diagnostic d'une hypertension arterielle pulmonaire.
FR2946349B1 (fr) Sequences, anticorps, procedes et necessaires pour la detection et le dosage in vitro de la periostine, en vue du diagnostic du suivi ou du pronostic de pathologies ou de phenomenes biologiques impliquant la periostine
WO2008145701A9 (en) Method for predicting the outcome of a critically ill patient
BR112013030646A2 (pt) uso diagnóstico de pró-somatostatina